ReviewAnalytical and bioanalytical chemistry2026
Carbohydrate-based biosensors for enhanced pathogen detection.
Review in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbohydrate-based biosensors represent a cutting-edge class of bioinspired diagnostic platforms that exploit the inherent specificity of glycan-protein interactions for pathogen detection. Carbohydrate-functionalized biosensing systems offer remarkable advantages in terms of sensitivity, selectivity, and biocompatibility, positioning them as compelling alternatives to conventional antibody- or nucleic acid-based assays. By mimicking natural recognition mechanisms, these interfaces enable rapid, scalable, and robust capture of microbial targets, even in complex biological matrices, thereby paving the way for detection platforms suitable for clinical diagnostics, environmental monitoring, and food safety applications. Recent advancements in glycan chemistry, nanotechnology, and surface functionalization, particularly the precise control of ligand density, orientation, and spatial arrangement, have significantly enhanced the performance of these biosensors. This review highlights the design principles, detection strategies, and emerging applications of carbohydrate-based biosensors targeting a broad spectrum of studied pathogens. It underscores their transformative potential in advancing point-of-care diagnostics and enhancing infectious disease surveillance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.